bioRxivPhysiologyPreprint
Adipose Tissue Pericellular Fibrosis, Weight Loss and Features of Metabolic Dysfunction-Associated Steatotic Liver Disease after Bariatric Surgery
Ève-Julie TremblayiD, Juan de Toro Martín, Stéfane LebeliD, Christian CoutureiD, Fannie Lajeunesse‐TrempeiD, Ina Maltais‐Payette, Giada OstinelliiD, Marie‐Claude VohliD, Laurent D. BierthoiD, Pascale MauriègeiD, André TchernofiD
Abstract
Introduction: Adipose tissue fibrosis has been associated with metabolic dysfunction-associated steatotic liver disease (MASLD) and suboptimal weight loss after bariatric surgery. The objective was to characterize changes in adipose tissue fibrosis and extracellular matrix (ECM) components in adipose tissues from two abdominal fat compartments, subcutaneous and omental, in response to bariatric surgery; and determine the effect of weight loss on the association between adipose tissue fibrosis and MASLD feature changes with weight loss. Methods: Liver and adipose tissue biopsy samples were obtained before and after weight loss from patients who underwent two-stage bariatric surgery. Adipose tissue pericellular fibrosis was evaluated histologically with picrosirius red staining for collagen quantification and normalized to adipocyte count per microscope field. Transcript levels of ECM remodeling and inflammatory genes were measured by RNA sequencing in subcutaneous adipose tissue pre- and post-surgery. Results: At baseline, adipose tissue pericellular fibrosis did not associate with MASLD features, metabolic dysfunction-associated steatohepatitis or hepatic fibrosis in patients with severe obesity. Changes in liver histology after surgery were unrelated to changes in adipose tissue fibrosis. Transcripts for most genes involved in ECM remodeling and inflammation were downregulated in subcutaneous fat one year after bariatric surgery. Omental, but not subcutaneous, adipose tissue fibrosis decreased after surgery when adjusted for cell number (mean {+/-} SD: 0.41 {+/-} 0.12 vs 0.32 {+/-} 0.08 {micro}m2/cell, p<0.005). Higher subcutaneous adipose tissue fibrosis correlated with reduced weight loss (estimate {+/-} SE: -2.04 {+/-} 0.99, p<0.05) and BMI loss (-0.73 {+/-} 0.35, p<0.05), while increased omental adipose tissue fibrosis after weight loss was associated with worsening hepatic fibrosis (0.31 {+/-} 0.14, p<0.05). Conclusion: In individuals with severe obesity undergoing bariatric surgery, adipose tissue fibrosis is poorly correlated with MASLD features. Notably, pericellular fibrosis in subcutaneous abdominal, but not omental, adipose tissue was associated with a reduced weight-loss response to surgery.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A Weight Loss Fibrotic Response in Visceral Fat Is Driven by Defective Lysosome-Dependent Collagenolysis
Clémentine Rebière, Amanda Oliveira, … Geneviève Marcelin·bioRxiv·Oct 5, 2026
- Pirfenidone improves adipose dysfunction and obesity-driven steatohepatitis via mTORC1 signaling
Yu Seol Lee, Ji Yun Bang, … Soo Han Bae·bioRxiv·Mar 21, 2026
- Rapid Remodeling of Human White Adipose Tissue Following Bariatric Surgery
Zinger Yang Loureiro, Gregory P. Westcott, … Evan D. Rosen·bioRxiv·Apr 15, 2026
- Adipose tissue cell states linked to progression and clinical subtypes of MASLD in human obesity
J.D. Madsen, Trine V. Dam, … S.F. Schmidt·bioRxiv·Sep 25, 2025
- Single cell-resolved transcriptional dynamics of human subcutaneous adipose tissue during lifestyle- and bariatric surgery-induced weight loss
Anne Loft, Rasmus Rydbirk, … Susanne Mandrup·Nature MetabolismPeer-reviewed·Jan 12, 2026
- Adipose Tissue Inflammation, Oxidative Stress, and Altered Adipogenesis Are Drivers of Dyslipidemia - A Multi-Omics Overview of Dyslipidemia in Obesity
Max S. Z. Zwartjes, Patrick A. de Jonge, … Max Nieuwdorp·bioRxiv·Oct 15, 2025